首页> 外文会议>International conference on cold regions engineering >EHBR (Enhanced Hybrid Biofilm Reactor) application in the wastewater treatment of pharmaceutical R D building
【24h】

EHBR (Enhanced Hybrid Biofilm Reactor) application in the wastewater treatment of pharmaceutical R D building

机译:EHBR(增强杂交生物膜反应器)在药品研发建筑的废水处理中的应用

获取原文

摘要

A study of the integrated EHBR system was conducted to investigate the performance of the system for treatment of pharmaceutical wastewater over 3 years. After 3 years of operation, the integrated EHBR system presented excellent ability of COD removal and notable impact resistance. The hydrolysis/acidification process could remove 7.2% of COD, 38.6% of TN and 9.5% of TP. And the removal efficiencies of COD, NH_4~+-N, TN, TP and SS in EHBR process were 85.5%, 96.2%, 71.1%, 72.5% and 81.1% respectively. After post-processingwith activated carbon adsorption, the effluent of integrated treatment EHBR system kept stable with COD below 200 mg/L, NH_4~+-N below 5 mg/L and TP below 3 mg/L.The integrated EHBR system could effectively and stably treat the high-loading mixed pharmaceutical wastewater from the high-tech pharmaceutical R&D building in Tianjincity of China, and the effluent quality could meet the wastewater discharge standard.
机译:进行了对综合EHBR系统的研究,探讨了系统治疗3年后药物废水的性能。经过3年的运行,集成的EHBR系统呈现出优异的COD去除能力和显着的抗冲击性。水解/酸化过程可以去除7.2%的COD,38.6%和9.5%的TP。 EHBR工艺中鳕鱼,NH_4〜+ -NN,TN,TP和SS的去除效率分别为85.5%,96.2%,71.1%,72.5%和81.1%。后处理后的活性炭吸附后,综合治疗的流出物EHBR系统在低于200mg / L的鳕鱼中保持稳定,低于5mg / L,TP低于3mg / L.集成的EHBR系统可以有效地和稳定地从中国天津的高科技制药研发建筑物稳定地治疗高压混合药物废水,污水质量可以满足废水排放标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号